Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
- 10 April 2015
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (8), 3548-3571
- https://doi.org/10.1021/jm502009h
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- NAD+metabolism: A therapeutic target for age-related metabolic diseaseCritical Reviews in Biochemistry and Molecular Biology, 2013
- Exploring the therapeutic space around NAD+The Journal of cell biology, 2012
- Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?Pharmacological Reviews, 2011
- The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling PathwaysEndocrine Reviews, 2010
- Emerging Roles of NAD + and Its Metabolites in Cell SignalingA report on the NAD2008 symposium, Hamburg, Germany, 14 to 17 September 2008.Science Signaling, 2009
- The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survivalFrontiers in Bioscience-Landmark, 2009
- NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicityThe AAPS Journal, 2006
- Poly(ADP-ribose): novel functions for an old moleculeNature Reviews Molecular Cell Biology, 2006
- The Sir2 Family of Protein DeacetylasesAnnual Review of Biochemistry, 2004
- The new life of a centenarian: signalling functions of NAD(P)Trends in Biochemical Sciences, 2004